↓ Skip to main content

Electroacupuncture for tapering off long-term benzodiazepine use: study protocol of randomized controlled trial

Overview of attention for article published in BMC Complementary Medicine and Therapies, March 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
126 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Electroacupuncture for tapering off long-term benzodiazepine use: study protocol of randomized controlled trial
Published in
BMC Complementary Medicine and Therapies, March 2017
DOI 10.1186/s12906-017-1692-5
Pubmed ID
Authors

Wing-Fai Yeung, Ka-Fai Chung, Zhang-Jin Zhang, Wai-Chi Chan, Shi-Ping Zhang, Roger Man-Kin Ng, Connie Lai-Wah Chan, Lai-Ming Ho, Yee-Man Yu, Li-Xing Lao

Abstract

Conventional approaches for benzodiazepine tapering have their limitations. Anecdotal studies have shown that acupuncture is a potential treatment for facilitating successful benzodiazepine tapering. As of today, there was no randomized controlled trial examining its efficacy and safety. The purpose of the study is to evaluate the efficacy of using electroacupuncture as an adjunct treatment to gradual tapering of benzodiazepine doses in complete benzodiazepine cessation in long-term benzodiazepine users. The study protocol of a randomized, assessor- and subject-blinded, controlled trial is presented. One hundred and forty-four patients with histories of using benzodiazepines in ≥50% of days for more than 3 months will be randomly assigned in a 1:1 ratio to receive either electroacupuncture or placebo electroacupuncture combined with gradual benzodiazepine tapering schedule. Both experimental and placebo treatments will be delivered twice per week for 4 weeks. Major assessments will be conducted at baseline, week 6 and week 16 post-randomization. Primary outcome is the cessation rate of benzodiazepine use. Secondary outcomes include the percentage change in the doses of benzodiazepine usage and the severity of withdrawal symptoms experienced based on the Benzodiazepine Withdrawal Symptom Questionnaire, insomnia as measured by the Insomnia Severity Index, and anxiety and depressive symptoms as evaluated by the Hospital Anxiety and Depression Scale. Adverse events will also be measured at each study visit. Results of this study will provide high quality evidence of the efficacy and safety of electroacupuncture as an adjunct treatment for benzodiazepine tapering in long-term users. ClinicalTrials.gov NCT02475538 .

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 126 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 126 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 23 18%
Student > Master 21 17%
Researcher 10 8%
Student > Postgraduate 6 5%
Student > Doctoral Student 6 5%
Other 19 15%
Unknown 41 33%
Readers by discipline Count As %
Medicine and Dentistry 39 31%
Nursing and Health Professions 17 13%
Psychology 5 4%
Biochemistry, Genetics and Molecular Biology 4 3%
Neuroscience 3 2%
Other 12 10%
Unknown 46 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 October 2021.
All research outputs
#7,014,252
of 22,963,381 outputs
Outputs from BMC Complementary Medicine and Therapies
#1,134
of 3,639 outputs
Outputs of similar age
#112,213
of 309,407 outputs
Outputs of similar age from BMC Complementary Medicine and Therapies
#30
of 115 outputs
Altmetric has tracked 22,963,381 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 3,639 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 309,407 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 115 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.